Treatment of Hepatitis C With the Earliest Protease Inhibitor-Based Therapy

被引：0
|
作者：
Smith, Zohreh Movahedi [1 ]
Brussman, Keith [1 ]
Nadir, Abdul [1 ]
机构：
[1] Maricopa Cty Gen Hosp, Phoenix, AZ 85008 USA
来源：
MAYO CLINIC PROCEEDINGS | 2014年 / 89卷 / 09期
关键词：
TRIPLE THERAPY; GENOTYPE;
D O I：
10.1016/j.mayocp.2014.06.020
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1319 / 1320
页数：3
相关论文
共 50 条
  • [1] Treatment of Chronic Hepatitis C With Protease Inhibitor-Based Therapy After Liver Transplantation
    Reddy, K. Rajender
    Everson, Gregory T.
    HEPATOLOGY, 2013, 58 (03) : 1181 - 1184
  • [2] Success with Protease Inhibitor-based Hepatitis C Therapy in an Urban, Primary Care-based Hepatitis C Clinic
    Kung, Robert
    Laney, Jason
    Miller, Lesley
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 : S137 - S137
  • [3] Risk of acute liver injury with protease inhibitor-based antiviral therapy for hepatitis C
    Torgersen, Jessie
    Newcomb, Craig W.
    Carbonari, Dena M.
    Rentsch, Christopher T.
    Park, Lesley S.
    Mehta, Rajni
    D'Addeo, Kathryn
    Taddei, Tamar
    Justice, Amy C.
    Lo Re, Vincent, III
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 614 - 615
  • [4] ADVERSE EVENT-RELATED TREATMENT COSTS ASSOCIATED WITH PROTEASE INHIBITOR-BASED COMBINATION THERAPY FOR HEPATITIS C
    Stephens, Jennifer M.
    Carter, John
    Gao, Xin
    Haider, Seema
    Rustgi, Vinod K.
    HEPATOLOGY, 2010, 52 (04) : 1241A - 1241A
  • [5] Dermatologic adverse events of protease inhibitor-based combination therapy in patients with chronic hepatitis C
    Klujszo, Elzbieta
    Parcheta, Piotr
    Zarebska-Michaluk, Dorota
    Ochwanowska, Ewa
    Witkowska, Anna
    Rakowska, Adriana
    Rudnicka, Lidia
    Kryczka, Wieslaw
    JOURNAL OF DERMATOLOGICAL CASE REPORTS, 2014, 8 (04): : 95 - 102
  • [6] Impact of adverse events on costs and quality of life in protease inhibitor-based combination therapy for hepatitis C
    Gao, Xin
    Stephens, Jennifer M.
    Carter, John A.
    Haider, Seema
    Rustgi, Vinod K.
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2012, 12 (03) : 335 - 343
  • [7] Protease inhibitor-based triple therapy in chronic hepatitis C: guidelines by the French Association for the Study of the Liver
    Leroy, Vincent
    Serfaty, Lawrence
    Bourliere, Marc
    Bronowicki, Jean-Pierre
    Delasalle, Patrick
    Pariente, Alexandre
    Pol, Stanislas
    Zoulim, Fabien
    Pageaux, Georges-Philippe
    LIVER INTERNATIONAL, 2012, 32 (10) : 1477 - 1492
  • [8] Evaluation of advanced fibrosis measured by transient elastography after hepatitis C virus protease inhibitor-based triple therapy
    Saez-Royuela, Federico
    Linares, Pedro
    Cervera, Luis A.
    Almohalla, Carolina
    Jorquera, Francisco
    Lorenzo, Sara
    Garcia, Isidro
    Karpman, Guillermo
    Badia, Ester
    Vallecillo, Maria A.
    Moncada, Adriana
    Calvo, Sara
    Olcoz, Jose L.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2016, 28 (03) : 305 - 312
  • [9] Protease inhibitor-based triple therapy is highly effective for hepatitis C recurrence after liver transplant: a multicenter experience
    Faisal, Nabiha
    Yoshida, Eric M.
    Bilodeau, Marc
    Wong, Philip
    Ma, Mang
    Burak, Kelly W.
    Al-Judaibi, Bandar
    Renner, Eberhard L.
    Lilly, Leslie B.
    ANNALS OF HEPATOLOGY, 2014, 13 (05) : 525 - 532
  • [10] Inhibitor-Based Therapeutics for Treatment of Viral Hepatitis
    Dey, Debajit
    Banerjee, Manidipa
    JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2016, 4 (03) : 248 - 257
12345